Literature DB >> 13638957

Treatment of cancer of the thyroid postoperatively with suppressive thyroid medication, radioactive iodine, and thyroid-stimulating hormone.

B CATZ, D W PETIT, H SCHWARTZ, F DAVIS, C McCAMMON, P STARR.   

Abstract

Entities:  

Keywords:  IODINE/radioactive; THYROID GLAND/neoplasms; THYROTROPIC HORMONE/therapeutic use

Mesh：

Substances：

Year:  1959        PMID： 13638957     DOI： 10.1002/1097-0142(195903/04)12:2<371::aid-cncr2820120221>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  6 in total

1.  Carcinoma of the thyroid.

Authors:  E M ALRICH; R H BLANK; M S ALLEN
Journal:  Ann Surg       Date:  1961-05       Impact factor: 12.969

2.  Hormonal and isotope measure in thyroid carcinoma.

Authors:  C G THOMAS; S G JENKINS
Journal:  Ann Surg       Date:  1963-06       Impact factor: 12.969

Review 3.  Overview of the management of differentiated thyroid cancer.

Authors:  Jyotika K Fernandes; Terry A Day; Mary S Richardson; Anand K Sharma
Journal:  Curr Treat Options Oncol       Date:  2005-01

4.  TSH suppression in the management of thyroid nodules and thyroid cancer.

Authors:  O H Clark
Journal:  World J Surg       Date:  1981-01       Impact factor: 3.352

Review 5.  Radiopharmaceutical therapy in cancer: clinical advances and challenges.

Authors:  George Sgouros; Lisa Bodei; Michael R McDevitt; Jessie R Nedrow
Journal:  Nat Rev Drug Discov       Date:  2020-07-29       Impact factor: 84.694

Review 6.  Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer.

Authors:  Massimiliano Pacilio; Miriam Conte; Viviana Frantellizzi; Maria Silvia De Feo; Antonio Rosario Pisani; Andrea Marongiu; Susanna Nuvoli; Giuseppe Rubini; Angela Spanu; Giuseppe De Vincentis
Journal:  Diagnostics (Basel)       Date:  2022-07-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.